Women who were diagnosed with colon cancer even after doctors initially dismissed blood in their stool are now sharing their inspiring stories. The exclusive report sheds light on the experiences of Sarah Beran and Brooks Bell, two women in their 30s who faced misdiagnoses before eventually being diagnosed with colorectal cancer. Their journey led them to collaborate on a mission to raise awareness about the importance of colonoscopies through their fashion brand, Worldclass.
:max_bytes(150000):strip_icc():format(jpeg)/brooks-bell-sarah-beran-103125-2-a703fb1afa0240f693d51240bcd86351.jpg)
In April 2020, amid the global upheaval due to the COVID-19 pandemic, Sarah Beran, then 39, sought medical attention for what she believed were intense IBS symptoms. Despite reassurances from her doctor about a potential parasite, Beran’s persistence led to a colonoscopy that revealed she had colorectal cancer. The subsequent treatment included chemotherapy, surgeries, and a spread to her lung, leading to further interventions and regular monitoring post-remission.
Brooks Bell, a successful CEO in her 30s, had a similar journey. Her diagnosis of stage three colon cancer followed initial dismissals by doctors attributing symptoms to a hemorrhoid. Bell’s advocacy for her health eventually led to the diagnosis and a decision to prioritize her treatment over professional commitments. Both women recognised the importance of self-advocacy and proactive healthcare in the face of initial misdiagnoses, a common challenge documented by the Colon Cancer Alliance.
The establishment of Worldclass by Beran and Bell marks their commitment to destigmatizing conversations around colonoscopies and colon cancer. Through innovative fashion campaigns and collaborations with celebrities like Ryan Reynolds, they aim to engage audiences and raise funds to support colonoscopy access for underinsured communities. The brand’s creative approach not only sparks dialogue but also contributes to preventive healthcare initiatives.
Understanding the critical role of colonoscopies in preventing and diagnosing colon cancer, Worldclass partners with institutions like the University of North Carolina to address barriers to care and enhance screening rates. Their holistic approach includes financial support for patients requiring assistance with healthcare costs and logistical challenges, ensuring access to life-saving procedures for those in need.
As colon cancer is projected to become a leading cause of cancer-related deaths in adults under 50 by 2030, Beran and Bell’s advocacy acquires heightened urgency. By sharing their stories and promoting early detection through colonoscopies, they aim to empower individuals to prioritise their health and seek timely medical interventions. Their collective efforts underscore the transformative impact of proactive healthcare measures in combating life-threatening illnesses.
Through Worldclass’s initiatives and partnerships, Beran and Bell demonstrate a commitment to driving tangible outcomes in cancer prevention and care. By allocating resources to address gaps in access to colonoscopies and amplifying awareness about preventive screenings, they exemplify a proactive approach towards public health challenges. Their dedication to empowering individuals to advocate for their health reflects a broader narrative of resilience and community-driven healthcare solutions.